RIZZI LAURA

Role
Assistant Professor  
Academic disciplines
Farmacologia (BIO/14)

Publications

  • Meanti, R., Bresciani, E., Rizzi, L., Coco, S., Zambelli, V., Dimitroulas, A., et al. (2023). Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis. CURRENT NEUROPHARMACOLOGY, 21(12), 2376-2394 [10.2174/1570159X20666220915103613]. Detail

  • Meanti, R., Licata, M., Rizzi, L., Bresciani, E., Molteni, L., Coco, S., et al. (2023). Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24020993]. Detail

  • Turati, M., Franchi, S., Crippa, M., Rizzi, L., Rigamonti, L., Sacerdote, P., et al. (2023). Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results. JOURNAL OF CLINICAL MEDICINE, 12(13) [10.3390/jcm12134330]. Detail

  • Bianchi, V., Rizzi, L., Somaa, F. (2023). The role of nutrition on Parkinson’s disease: a systematic review. NUTRITIONAL NEUROSCIENCE, 26(7), 605-628 [10.1080/1028415X.2022.2073107]. Detail

  • Re, F., Giorgetti, S., Biondi, B., Scapin, S., Mantegazza, F., Cassina, V., et al. (2023). Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity. ANNALS OF MEDICINE, 55(1) [10.1080/07853890.2023.2205659]. Detail

Research projects

Disease-modifying effects of hexarelin and JMV2894 in experimental models of multiple sclerosis
Year: 2023
Call: FAQC 2023 - prima finestra
Grantors: Università degli Studi di MILANO-BICOCCA
PNRR per la Missione 4, componente 2 Investimento 1.1- Avviso 104/2022 | Development of Growth Hormone Secretagogues as novel therapeutical tools for the treatment of multiple sclerosis
Year: 2022
Call: Bando PRIN 2022
Grantors: MINISTERO DELL'UNIVERSITA' E DELLA RICERCA (MUR)

Awards

Awards

  • Best poster communication award, Società Italiana di Farmacologia -SIF, 2019